114 related articles for article (PubMed ID: 9066643)
21. [Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone].
Mueck AO; Seeger H; Wallwiener D
Zentralbl Gynakol; 2001 Nov; 123(11):648-54. PubMed ID: 11797164
[TBL] [Abstract][Full Text] [Related]
22. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice.
Desreux J; Kloosterboer H; Noël A; Frankenne F; Lemaire M; Putman M; Foidart JM
Gynecol Obstet Invest; 2007; 63(1):31-8. PubMed ID: 16899995
[TBL] [Abstract][Full Text] [Related]
23. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
24. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
25. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
26. Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone.
Maran A; Shogren K; Zhang M; Yaszemski MJ; Hefferan TE; Spelsberg TC; Kloosterboer HJ; Turner RT
Bone; 2006 Sep; 39(3):523-9. PubMed ID: 16707283
[TBL] [Abstract][Full Text] [Related]
27. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
[TBL] [Abstract][Full Text] [Related]
28. Correlation of estrogen sulfotransferase activity and proliferation in normal and carcinomatous human breast. A hypothesis.
Pasqualini JR; Chetrite GS
Anticancer Res; 2007; 27(5A):3219-25. PubMed ID: 17970064
[TBL] [Abstract][Full Text] [Related]
29. Effects of progestagens and Org OD14 in in vitro and in vivo tumor models.
Kloosterboer HJ; Schoonen WG; Deckers GH; Klijn JG
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):311-8. PubMed ID: 8043494
[TBL] [Abstract][Full Text] [Related]
30. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
31. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase.
Raobaikady B; Parsons MF; Reed MJ; Purohit A
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):154-60. PubMed ID: 17467267
[TBL] [Abstract][Full Text] [Related]
32. Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Verheul HA; Blok LJ; Burger CW; Hanifi-Moghaddam P; Kloosterboer HJ
Reprod Sci; 2007 Feb; 14(2):160-8. PubMed ID: 17636227
[TBL] [Abstract][Full Text] [Related]
33. Tibolone: a compound with tissue specific inhibitory effects on sulfatase.
de Gooyer ME; Kleyn GT; Smits KC; Ederveen AG; Verheul HA; Kloosterboer HJ
Mol Cell Endocrinol; 2001 Oct; 183(1-2):55-62. PubMed ID: 11604225
[TBL] [Abstract][Full Text] [Related]
34. Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.
Chetrite G; Paris J; Botella J; Pasqualini JR
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):525-31. PubMed ID: 8918978
[TBL] [Abstract][Full Text] [Related]
35. Tibolone and metabolites induce prolactin production in human endometrial stromal cells in vitro: evidence for cell-specific metabolism.
Groothuis PG; De Gooyer ME; ten Kate J; Menheere PP; Dunselman GA; de Goeij AF; Verbost P; Ederveen AG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):152-60. PubMed ID: 16781141
[TBL] [Abstract][Full Text] [Related]
36. Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2002; 23(2):127-30. PubMed ID: 12013108
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Werner HM; Franke HR; Vermes I
Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
[TBL] [Abstract][Full Text] [Related]
38. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines.
Chetrite GS; Ebert C; Wright F; Philippe AC; Pasqualini JR
J Steroid Biochem Mol Biol; 1999; 70(1-3):39-45. PubMed ID: 10529001
[TBL] [Abstract][Full Text] [Related]
39. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
